Corcept Therapeutics Incorporated
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CORT research report →
About the company
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily. Korlym is prescribed for adult patients diagnosed with endogenous Cushing's syndrome who suffer from hyperglycemia due to hypercortisolism, particularly those with type 2 diabetes or glucose intolerance, and for whom surgical options have either failed or are not viable.
- CEO
- Joseph K. Belanoff
- IPO
- 2004
- Employees
- 500
- HQ
- Menlo Park, CA, US
Price Chart
- Market Cap
- $9.68B
- P/E
- 200.47
- P/S
- 12.59
- P/B
- 14.77
- EV/EBITDA
- 677.11
- Div Yield
- 0.00%
- Gross Margin
- 98.25%
- Op Margin
- -1.07%
- Net Margin
- 6.23%
- ROE
- 7.50%
- ROIC
- -1.23%
- Revenue
- $761.41M · 12.79%
- Net Income
- $99.65M · -28.68%
- EPS
- $0.95 · -29.63%
- Op Income
- $44.80M
- FCF YoY
- -27.62%
- 52W High
- $91.00
- 52W Low
- $28.66
- 50D MA
- $66.34
- 200D MA
- $60.59
- Beta
- 0.46
- Avg Volume
- 1.09M
Get TickerSpark's AI analysis on CORT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 16, 26 | WILSON JAMES N | sell | 4,177 |
| Jun 16, 26 | WILSON JAMES N | sell | 5,823 |
| Jun 17, 26 | MAHONEY DAVID L | sell | 20,000 |
| Jun 15, 26 | Mokari Atabak | other | 40,000 |
| Jun 15, 26 | Mokari Atabak | sell | 9,434 |
| Jun 15, 26 | Mokari Atabak | sell | 11,081 |
| Jun 15, 26 | Mokari Atabak | other | 40,000 |
| Jun 15, 26 | Mokari Atabak | sell | 19,483 |
| Jun 15, 26 | Mokari Atabak | sell | 2 |
| Jun 2, 26 | Guyer William | other | 20,000 |
Our CORT coverage
Recent articles, reports, and earnings notes.
No research on CORT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CORT report →Similar companies
Peers in the same neighborhood.